Radio and PodcastLive Radio & PodcastsScience & Medicine
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publicati...
About This Episode
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates is an episode from Lung Cancer Update by Dr. Neil Love. Dr Jacob Sands from Dana-Farber Cancer Inst...
Podcast
This episode belongs to Lung Cancer Update.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 14, 2025, 23:19 long, audio available.
Related Episodes
Continue listening to more episodes from Lung Cancer Update.
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
Dec 10, 2025 - 01:05:13
Questions About This Episode
What is Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates about?
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publications here .
Where can I listen to Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates?
You can listen to Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates from?
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates is an episode from Lung Cancer Update by Dr. Neil Love.
How long is this episode?
This episode is 23:19 long.
When was this episode published?
This episode was published on Sep 14, 2025.
Can I save Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Lung Cancer Update?
Yes. This page shows related episodes from Lung Cancer Update when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates?
You can listen to Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates is from Lung Cancer Update by Dr. Neil Love.
What are the episode details?
Published Sep 14, 2025 and 23:19 long